| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Commentary on “Lung Cancer Screening in High-Risk Populations”
|
Mulshine, James L.
|
|
1999
|
1 |
2 |
p. 107-
1 p.
|
artikel
|
| 2 |
Commentary on “Lung Cancer: Value of Various Imaging Modalities”
|
Gupta, Naresh C.
|
|
1999
|
1 |
2 |
p. 137-
1 p.
|
artikel
|
| 3 |
Commentary on “Sequential Chemotherapy: Rationale and Clinical Trial Design in Advanced Non–Small-Cell Lung Carcinoma”
|
Georgoulias, Vassilis
|
|
1999
|
1 |
2 |
p. 129-
1 p.
|
artikel
|
| 4 |
Commentary on “Sequential Chemotherapy: Rationale and Clinical Trial Design in Advanced Non–Small-Cell Lung Carcinoma”
|
Eckhardt, John R.
|
|
1999
|
1 |
2 |
p. 128-
1 p.
|
artikel
|
| 5 |
Commentary on “The Benefit of Support Group Participation to Lung Cancer Survivors”
|
Pass, Harvey I.
|
|
1999
|
1 |
2 |
p. 119-
1 p.
|
artikel
|
| 6 |
Commentary on “The Benefit of Support Group Participation to Lung Cancer Survivors”
|
Evans, William K.
|
|
1999
|
1 |
2 |
p. 118-
1 p.
|
artikel
|
| 7 |
Docetaxel and Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Multicenter Phase II Trial
|
Belani, Chandra P.
|
|
1999
|
1 |
2 |
p. 144-150
7 p.
|
artikel
|
| 8 |
1999 European Cancer Conference Summary of Phase III Trials
|
|
|
1999
|
1 |
2 |
p. 90-91
2 p.
|
artikel
|
| 9 |
Lung Cancer Screening in High-Risk Populations
|
Siegfried, Jill M.
|
|
1999
|
1 |
2 |
p. 100-106
7 p.
|
artikel
|
| 10 |
Lung Cancer: Value of Various Imaging Modalities
|
Rivera-Garcia, Robert
|
|
1999
|
1 |
2 |
p. 130-136
7 p.
|
artikel
|
| 11 |
Phase I Study of Bryostatin-1 in Combination with Cisplatin in Treating Patients with Metastatic or Unresectable Solid Tumors Including Non–Small-Cell Lung Cancer
|
Lenz, Heinz-Josef
|
|
1999
|
1 |
2 |
p. 151-152
2 p.
|
artikel
|
| 12 |
Randomized Phase III Trial Comparing Cisplatin/Gemcitabine/Vinorelbine to Cisplatin/Gemcitabine or Cisplatin/Vinorelbine in Patients with Advanced NSCLC
|
|
|
1999
|
1 |
2 |
p. 94-95
2 p.
|
artikel
|
| 13 |
Randomized Phase III Trial Comparing Docetaxel to Best Supportive Care for Previously Untreated Advanced NSCLC1
|
|
|
1999
|
1 |
2 |
p. 92-93
2 p.
|
artikel
|
| 14 |
Sequential Chemotherapy: Rationale and Clinical Trial Design in Advanced Non–Small-Cell Carcinoma
|
Edelman, Martin J.
|
|
1999
|
1 |
2 |
p. 122-127
6 p.
|
artikel
|
| 15 |
The Anti-Apoptosis Survivin Gene and its Role in Human Cancer: An Overview
|
Escuín, Daniel
|
|
1999
|
1 |
2 |
p. 138-143
6 p.
|
artikel
|
| 16 |
The Benefits of Support Group Participation to Lung Cancer Survivors — An Evaluation
|
McCarthy, Margaret M.
|
|
1999
|
1 |
2 |
p. 110-117
8 p.
|
artikel
|
| 17 |
Twice-Weekly Gemcitabine and Concurrent Thoracic Radiation for Advanced Non–Small-Cell Lung Cancer
|
Blackstock, A. William
|
|
1999
|
1 |
2 |
p. 153-154
2 p.
|
artikel
|
Tijdschrift beschrijving